Approval · Notice of Compliance 29062 · 2022
ACYCLOVIR SODIUM INJECTION: Notice of Compliance 29062
Issued September 22, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29062
- Date
- September 22, 2022
- Company
- Eugia Pharma Inc.Woodbridge, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement Between Two Companies
- Canadian reference product
- ACYCLOVIR SODIUM INJECTION
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACYCLOVIR SODIUM INJECTION | 02531224 | Marketed |
Medicinal ingredients
- ACYCLOVIR 50 MG per ML